Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC.
作者信息
Di Fiore F, Charbonnier F, Martin C, Frerot S, Olschwang S, Wang Q, Boisson C, Buisine M-P, Nilbert M, Lindblom A, Frebourg T
出版信息
J Med Genet. 2004 Jan;41(1):18-20. doi: 10.1136/jmg.2003.012062.
Abstract
摘要
相似文献
1
Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC.错配修复（MMR）基因的基因组重排筛查必须纳入遗传性非息肉病性结直肠癌（HNPCC）的常规诊断中。
J Med Genet. 2004 Jan;41(1):18-20. doi: 10.1136/jmg.2003.012062.
2
[The mismatch-repair genes and colon cancer].[错配修复基因与结肠癌]
Duodecim. 1996;112(4):337-40.
3
Novel splicing associations of hereditary colon cancer related DNA mismatch repair gene mutations.遗传性结肠癌相关DNA错配修复基因突变的新型剪接关联
J Med Genet. 2004 Jul;41(7):e95. doi: 10.1136/jmg.2003.017269.
4
Prevalence of the mismatch-repair-deficient phenotype in colonic adenomas arising in HNPCC patients: results of a 5-year follow-up study.HNPCC患者结肠腺瘤中错配修复缺陷表型的患病率：一项5年随访研究的结果
Int J Colorectal Dis. 2006 Oct;21(7):632-41. doi: 10.1007/s00384-005-0073-6. Epub 2006 Mar 2.
5
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X.阿姆斯特丹-I标准家族中无错配修复缺陷的癌症发病率较低：X型家族性结直肠癌
JAMA. 2005 Apr 27;293(16):1979-85. doi: 10.1001/jama.293.16.1979.
6
Assay validation for identification of hereditary nonpolyposis colon cancer-causing mutations in mismatch repair genes MLH1, MSH2, and MSH6.用于鉴定错配修复基因MLH1、MSH2和MSH6中遗传性非息肉病性结直肠癌致病突变的检测验证。
J Mol Diagn. 2005 Oct;7(4):525-34. doi: 10.1016/S1525-1578(10)60584-3.
7
DNA mismatch repair genes and colorectal cancer.DNA错配修复基因与结直肠癌
Gut. 2000 Jul;47(1):148-53. doi: 10.1136/gut.47.1.148.
8
[Hereditary carcinoma: pathogenesis and diagnosis].[遗传性癌：发病机制与诊断]
Zentralbl Chir. 2000;125 Suppl 1:8-11.
9
Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.遗传性非息肉病性结直肠癌：诊断策略及其影响。
Evid Rep Technol Assess (Full Rep). 2007 May(150):1-180.
10
Decoding hereditary colorectal cancer.解读遗传性结直肠癌
N Engl J Med. 2006 Jun 29;354(26):2815-7. doi: 10.1056/NEJMe068110.
引用本文的文献
1
Detection of copy-number variations from NGS data using read depth information: a diagnostic performance evaluation.基于测序深度信息的 NGS 数据拷贝数变异检测：诊断性能评估。
Eur J Hum Genet. 2021 Jan;29(1):99-109. doi: 10.1038/s41431-020-0672-2. Epub 2020 Jun 26.
2
Challenges in returning results in a genomic medicine implementation study: the Return of Actionable Variants Empirical (RAVE) study.基因组医学实施研究中的结果反馈挑战：可操作变异实证反馈（RAVE）研究
NPJ Genom Med. 2020 May 4;5:19. doi: 10.1038/s41525-020-0127-2. eCollection 2020.
3
Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine.结直肠癌中较少突变基因的可操作性及其在精准医学中的作用。
Biomolecules. 2020 Mar 20;10(3):476. doi: 10.3390/biom10030476.
4
Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population.家族性/遗传性癌症综合征：聚焦高度近亲结婚的阿拉伯人群体。
NPJ Genom Med. 2020 Feb 3;5:3. doi: 10.1038/s41525-019-0110-y. eCollection 2020.
5
Systematic study on genetic and epimutational profile of a cohort of Amsterdam criteria-defined Lynch Syndrome in Singapore.新加坡一组符合阿姆斯特丹标准的林奇综合征患者的基因和表观突变特征的系统研究。
PLoS One. 2014 Apr 7;9(4):e94170. doi: 10.1371/journal.pone.0094170. eCollection 2014.
6
Partial duplication of MSH2 spanning exons 7 through 14 in Lynch syndrome.Lynch 综合征中 MSH2 外显子 7 至 14 的部分重复。
J Gastroenterol. 2013 Jun;48(6):770-6. doi: 10.1007/s00535-013-0804-3. Epub 2013 Apr 18.
7
Contribution of large genomic rearrangements in Italian Lynch syndrome patients: characterization of a novel alu-mediated deletion.意大利林奇综合征患者中大片段基因组重排的贡献：一种新型 Alu 介导缺失的特征。
Biomed Res Int. 2013;2013:219897. doi: 10.1155/2013/219897. Epub 2012 Dec 30.
8
Screening of the DNA mismatch repair genes MLH1, MSH2 and MSH6 in a Greek cohort of Lynch syndrome suspected families.对希腊林奇综合征疑似家系中 DNA 错配修复基因 MLH1、MSH2 和 MSH6 的筛查。
BMC Cancer. 2010 Oct 11;10:544. doi: 10.1186/1471-2407-10-544.
9
Some aspects of molecular diagnostics in Lynch syndrome.林奇综合征分子诊断的某些方面。
Hered Cancer Clin Pract. 2006 Dec 15;4(4):197-205. doi: 10.1186/1897-4287-4-4-197.
10
Partial loss of heterozygosity events at the mutated gene in tumors from MLH1/MSH2 large genomic rearrangement carriers.肿瘤中突变基因的杂合性丢失事件发生在 MLH1/MSH2 大片段基因重排携带者中。
BMC Cancer. 2009 Nov 20;9:405. doi: 10.1186/1471-2407-9-405.
Zotero 插件